1. Stocks
    2. /
  2. Clinuvel Pharmaceuticals (ASX: CUV)
    3. /

Clinuvel Pharmaceuticals (ASX: CUV) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Clinuvel Pharmaceuticals Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Clinuvel Pharmaceuticals (ASX: CUV)
    Latest News

    a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
    Healthcare Shares

    Bell Potter names the best ASX healthcare stocks to buy now

    | James Mickleboro

    The broker has good things to say about these stocks.

    Read more »

    A man clenches his fists in excitement as gold coins fall from the sky.
    Share Gainers

    Why Clinuvel, Orthocell, Vulcan, and Wildcat shares are storming higher

    | James Mickleboro

    These shares are having a good time on hump day. But why?

    Read more »

    A man sits thoughtfully on the couch with a laptop on his lap.
    Broker Notes

    8 ASX All Ords shares bumped up to 'strong buy' status in August

    | Bronwyn Allen

    These ASX companies attracted upgraded ratings from the brokers last month.

    Read more »

    Doctor doing a telemedicine using laptop at a medical clinic
    Earnings Results

    Guess which ASX All Ords healthcare share just rocketed 13% on its FY 2024 results!

    | Bernd Struben

    Investors are sending the ASX All Ords healthcare share flying higher on Thursday. But why?

    Read more »

    Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
    Share Gainers

    Why Bega Cheese, Clinuvel, Dusk, and Omni Bridgeway shares are rocketing today

    | James Mickleboro

    These shares are standing out with strong gains on Thursday. But why?

    Read more »

    Smiling man sits in front of a graph on computer while using his mobile phone.
    Broker Notes

    Broker says buy the dip on these 4 ASX shares

    | Bronwyn Allen

    Top broker Morgans has add ratings on four ASX shares that have dipped significantly over the past month.

    Read more »

    A worried man holds his head and look at his computer.
    Share Fallers

    Why Clinuvel, Mesoblast, Red Hill, and Resimac shares are sinking today

    | James Mickleboro

    These shares are having a tough time on Tuesday. But why?

    Read more »

    a woman holds her hands to her temples as she sits in front of a computer screen with a concerned look on her face.
    Share Fallers

    Why Bowen Coking Coal, Clinuvel, Meteoric Resources, and Pilbara Minerals shares are falling

    | James Mickleboro

    These shares are starting the week in the red. But why?

    Read more »

    A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
    Share Gainers

    Why Clinuvel, Guzman y Gomez, Magellan, and Sandfire shares are charging higher

    | James Mickleboro

    These shares are ending the week with a bang. But why?

    Read more »

    Shot of a young scientist using a digital tablet while working in a lab.
    Healthcare Shares

    Why is this ASX 300 healthcare stock surging 12% today?

    | James Mickleboro

    An announcement is getting investors excited today. Let's find out what's happening.

    Read more »

    A young man talks tech on his phone while looking at a laptop. A financial graph is superimposed across the image.
    Broker Notes

    Guess which ASX 300 share could rise over 50%

    | James Mickleboro

    Bell Potter sees huge upside for this buy-rated stock. Let's see why it is bullish.

    Read more »

    Smiling man with phone in wheelchair watching stocks and trends on computer
    Share Market News

    5 things to watch on the ASX 200 on Tuesday

    | James Mickleboro

    A better session is expected for Aussie investors today.

    Read more »

    Frequently Asked Questions

    Yes, Clinuvel Pharmaceuticals has historically paid one unfranked shareholder dividend a year.

    Clinuvel Pharmaceuticals generally pays its shareholder dividend in September.

    Clinuvel Pharmaceuticals does not have a dividend reinvestment plan.

    Clinuvel Pharmaceuticals Limited listed on the ASX on 13 February 2001.

    CUV ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Clinuvel Pharmaceuticals

    Clinuvel Pharmaceuticals Ltd (ASX: CUV) is an Australian-based global biopharmaceutical company developing drugs for the treatment of genetic and vascular disorders. Its principal product SCENESSE is a drug for an inherited disorder, erythropoietic protoporphyria, that causes an intolerance to light.

    Its pioneering work aims at preventing the symptoms of skin diseases related to exposure to UV radiation and at repigmentation of the skin due to depigmentation disorders. Geographically, the company derives the majority of its revenue from its US and European markets.

     

    Profile

    since

    Note